Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIS-guided closed-loop target-controlled infusion of ciprofol versus propofol in patients with lung tumors
ChiCTR2600132616Phase 4Not yet recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Sep 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and propofol in lung neoplasm (2 arms), sponsored by The Fourth Hospital of Hebei Medical University. Primary endpoint: 15-item Quality of Recovery scale. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
lung neoplasm
Beyond the preview
Go deeper on ChiCTR2600132616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132616.